Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Essential Medicines for Universal Health Coverage; [Основные (Жизненно Важные) Лекарства Для Всеобщего Охвата Медицинской Помощью] Publisher



Wirtz VJ1 ; Hogerzeil HV2 ; Gray AL3 ; Bigdeli M4 ; De Joncheere CP5 ; Ewen MA6 ; Gyansalutterodt M7 ; Jing S8 ; Luiza VL9 ; Mbindyo RM10 ; Moller H11 ; Moucheraud C12 ; Pecoul B13 ; Rago L14 Show All Authors
Authors
  1. Wirtz VJ1
  2. Hogerzeil HV2
  3. Gray AL3
  4. Bigdeli M4
  5. De Joncheere CP5
  6. Ewen MA6
  7. Gyansalutterodt M7
  8. Jing S8
  9. Luiza VL9
  10. Mbindyo RM10
  11. Moller H11
  12. Moucheraud C12
  13. Pecoul B13
  14. Rago L14
  15. Rashidian A15, 16
  16. Rossdegnan D17, 18, 19
  17. Stephens PN20
  18. Teerawattananon Y21
  19. Thoen EFM2
  20. Wagner AK17, 18
  21. Yadav P22
  22. Reich MR23
Show Affiliations
Authors Affiliations
  1. 1. Department of Global Health, Center for Global Health and Development, Boston University School of Public Health, Boston, MA, United States
  2. 2. Global Health Unit, Department of Health Sciences, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands
  3. 3. Division of Pharmacology, Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, Durban, South Africa
  4. 4. World Health Organization, Geneva, Switzerland
  5. 5. Department of Essential Medicines and Health Products, Geneva, Switzerland
  6. 6. Health Action International, Amsterdam, Netherlands
  7. 7. Ministry of Health, Accra, Ghana
  8. 8. Peking Union Medical College School of Public Health, Beijing, China
  9. 9. National School of Public Health Sergio Arouca, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
  10. 10. World Health Organization, Country Office, Nairobi, Kenya
  11. 11. United Nations Children's Fund, Supply Division, Copenhagen, Denmark
  12. 12. UCLA Fielding School of Public Health, University of California, Los Angeles, CA, United States
  13. 13. Drugs for Neglected Diseases Initiative, Geneva, Switzerland
  14. 14. Regulation of Medicines and other Health Technologies, Geneva, Switzerland
  15. 15. Department of Information, Evidence and Research, Eastern Mediterranean Region, World Health Organization, Cairo, Egypt
  16. 16. School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  17. 17. Research, Eastern Mediterranean Region, World Health Organization, Cairo, Egypt
  18. 18. Harvard Medical School, Boston, MA, United States
  19. 19. Harvard Pilgrim Health Care Institute, Boston, MA, United States
  20. 20. IMS Health, London, United Kingdom
  21. 21. Health Intervention and Technology Assessment Program (HITAP), Thai Ministry of Public Health Nonthaburi, Thailand
  22. 22. William Davidson Institute at the University of Michigan, Ann Arbor, MI, United States
  23. 23. Harvard T H Chan School of Public Health, Boston, MA, United States

Source: Kazan Medical Journal Published:2019


Abstract

[No abstract available]
Other Related Docs
10. Antioxidant Supplements and Breast Cancer: A Systematic Review and Meta-Analysis, International Journal of Cancer Management (2018)
17. Improving Adverse Drug Event Reporting by Health Care Professionals, Cochrane Database of Systematic Reviews (2017)
18. Improving Adverse Drug Event Reporting by Healthcare Professionals, Cochrane Database of Systematic Reviews (2024)
19. Providing a Framework for Assessment of the Access to Medicine, DARU# Journal of Pharmaceutical Sciences (2019)